RISORDAN 10 mg/10 ml, solution for injection (IV, intracoronaire) in an ampoule 50 ampoules of 10 ml
Active ingredients: Isosorbide dinitrate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection50 ampoules of 10 mlintracoronaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RISORDAN 10 mg/10 ml, solution injectable (IV, intracoronaire) en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intracoronaire;intraveineuse
- Presentation description
- 50 ampoule(s) en verre de 10 ml
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Aug 2024
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64822161CIP75557925CIP133400955579250Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DINITRATE D'ISOSORBIDEsolution | 10 mg · une ampoule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.